According to the structure of specifying ‘essential diagnostic criteria’ of the upcoming 5th edition of the WHO classification of CNS tumors, we suggest (a) the specific signature by DNA methylation profiling or (b) the combination GFAP expression and PLAGL1 fusions as essential diagnostic criteria for these tumors. This evidence concerns the gene PLAGL1 and central nervous system neoplasm.